Literature DB >> 17981642

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.

Yiyun Cheng1, Jinrong Wang, Tingling Rao, Xiaoxiao He, Tongwen Xu.   

Abstract

Dendrimers are new artificial macromolecules which have the structure like a tree. They are hyperbranched and monodisperse three-dimensional molecules with defined molecular weights, large numbers of functional groups on the surface and well-established host-guest entrapment properties. Recently, dendrimers have successfully proved themselves as promising nanocarriers for drug delivery because they can render drug molecules a greater water-solubility, bioavailability, and biocompatibility. In this review, recent progress in the pharmaceutical applications of dendrimers as delivery systems for drugs, particularly, the non-steroidal anti-inflammatory, anti-microbial/anti-viral and potent anti-cancer drugs is discussed. Three possible interaction mechanisms between dendrimers and drug molecules are presented. In addition, the pharmacodynamic and pharmacokinetic properties of both dendrimer/drug complex and dendrimer-drug conjugation after their administration to animals are evaluated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981642     DOI: 10.2741/2774

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  19 in total

Review 1.  Cancer detection and treatment: the role of nanomedicines.

Authors:  Justin LaRocque; Dhruba J Bharali; Shaker A Mousa
Journal:  Mol Biotechnol       Date:  2009-03-17       Impact factor: 2.695

Review 2.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

3.  Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria.

Authors:  Swati Biswas; Namita S Dodwadkar; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

4.  Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.

Authors:  Andrzej Myc; Jolanta Kukowska-Latallo; Peter Cao; Ben Swanson; Julianna Battista; Thomas Dunham; James R Baker
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

5.  Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio.

Authors:  Alireza Nomani; Ismaeil Haririan; Ramin Rahimnia; Shamileh Fouladdel; Tarane Gazori; Rassoul Dinarvand; Yadollah Omidi; Ebrahim Azizi
Journal:  Int J Nanomedicine       Date:  2010-05-13

6.  Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D,L-lactide) core-shell nanoparticles.

Authors:  Arunvel Kailasan; Quan Yuan; Hu Yang
Journal:  Acta Biomater       Date:  2009-08-27       Impact factor: 8.947

7.  Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.

Authors:  Erika N Cline; Ming-Hsin Li; Seok Ki Choi; Jeffrey F Herbstman; Neha Kaul; Edgar Meyhöfer; Georgios Skiniotis; James R Baker; Ronald G Larson; Nils G Walter
Journal:  Biomacromolecules       Date:  2013-02-21       Impact factor: 6.988

Review 8.  Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.

Authors:  Emily Gullotti; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

9.  Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.

Authors:  Bing Wang; Raghavendra S Navath; Roberto Romero; Sujatha Kannan; Rangaramanujam Kannan
Journal:  Int J Pharm       Date:  2009-05-20       Impact factor: 5.875

10.  Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.

Authors:  Marco A Alcala; Shu Ying Kwan; Chad M Shade; Megan Lang; Hyounsoo Uh; Manyan Wang; Stephen G Weber; David L Bartlett; Stéphane Petoud; Yong J Lee
Journal:  Nanomedicine       Date:  2010-10-12       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.